0001127602-12-006373.txt : 20120216 0001127602-12-006373.hdr.sgml : 20120216 20120216161838 ACCESSION NUMBER: 0001127602-12-006373 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120214 FILED AS OF DATE: 20120216 DATE AS OF CHANGE: 20120216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 BUSINESS PHONE: 9735202700 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PREVOZNIK MICHAEL E CENTRAL INDEX KEY: 0001222679 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12215 FILM NUMBER: 12619613 MAIL ADDRESS: STREET 1: 3 GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940 4 1 form4.xml PRIMARY DOCUMENT X0304 4 2012-02-14 0001022079 QUEST DIAGNOSTICS INC DGX 0001222679 PREVOZNIK MICHAEL E C/O QUEST DIAGNOSTICS INCORPORATED 3 GIRALDA FARMS MADISON NJ 07940 1 SVP & General Counsel Common Stock 2012-02-14 4 S 0 1502 57.3653 D 36996 D Common Stock 2012-02-14 4 S 0 3042 57.416 D 33954 D Common Stock 2012-02-15 4 F 0 836 56.80 D 33118 D Common Stock 4372 I 401k/SDCP The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on February 7, 2011. Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units. This transaction was executed in multiple trades at prices ranging from $57.31 to $57.4001. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $57.3305 to $57.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The amount includes exempt purchases made under the Company's stock purchase plan. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k) and/or Supplemental Deferred Compensation Plan. The information was obtain from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. /s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Michael E. Prevoznik 2012-02-16